Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
K
Kolon Life Science Inc
KOSDAQ:102940
Kolon Life Science Inc
KOSDAQ:102940
Price:
12 770
KRW
0.71%
Market Closed
Market Cap:
₩167.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
K
|
Kolon Life Science Inc
KOSDAQ:102940
|
KR |
|
MorphoSys AG
NASDAQ:MOR
|
DE |
|
Tiziana Life Sciences Ltd
NASDAQ:TLSA
|
UK |
|
Tocvan Ventures Corp
F:TV3
|
CA |
|
Dexerials Corp
OTC:DEXCF
|
JP |
|
Compania de Minas Buenaventura SAA
F:MBU
|
PE |
|
P
|
Peptron Inc
KOSDAQ:087010
|
KR |
|
S
|
Southern Seed Corp
VN:SSC
|
VN |
|
Desane Group Holdings Ltd
ASX:DGH
|
AU |
|
A
|
Atlassian Corp
SWB:48D
|
AU |
|
P
|
PioLink Inc
KOSDAQ:170790
|
KR |
|
M
|
Minth Group Ltd
HKEX:425
|
TW |
|
Unicharm Corp
OTC:UNCHF
|
JP |
|
Prada SpA
HKEX:1913
|
IT |
|
Roots Corp
TSX:ROOT
|
CA |
|
Akron PAO
MOEX:AKRN
|
RU |
|
Orege SA
PAR:OREGE
|
FR |
|
S
|
Shake Shack Inc
F:9SH
|
US |
|
Entravision Communications Corp
NYSE:EVC
|
US |
|
M
|
Mattel Inc
XMUN:MTT
|
US |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Kolon Life Science Inc's stock price target?
Not Available
Kolon Life Science Inc does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Kolon Life Science Inc?
Projected CAGR
8%
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next -8 years is 8%.
What is the Gross Profit forecast for Kolon Life Science Inc?
Projected CAGR
8%
8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next -8 years is 8%.
What is the Net Income forecast for Kolon Life Science Inc?
Projected CAGR
83%
83%
Over the last 13 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next -8 years is 83%.